Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2022-07-15 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended May 31, 2022. It contains detailed unaudited condensed consolidated financial statements, including balance sheets, statements of operations, stockholders' equity, cash flows, and notes. The length is substantial (15,000 characters), and it includes substantive financial data and management discussion. This matches the definition of an Interim / Quarterly Report (IR). Q1 2023
2022-07-15 English
Other.pdf
Regulatory Filings
2022-07-14 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a detailed announcement of financial results for the first fiscal quarter of 2022, including revenue, profit growth, and operational highlights. It references the upcoming filing of a quarterly report on Form 10-Q with the SEC and SEDAR, indicating this is a preliminary earnings release rather than the full interim report itself. The document also announces management changes and provides an earnings call invitation. The length (over 11,000 characters) and detailed financial data suggest it is more than a brief earnings summary, but since it explicitly states the formal quarterly report will be filed later, this document is best classified as an Earnings Release (ER) rather than an Interim/Quarterly Report (IR). Q1 2023
2022-07-14 English
News release - English.pdf
Regulatory Filings
2022-06-29 English
Other.pdf
Regulatory Filings
2022-06-10 English
News release - English.pdf
Regulatory Filings
2022-06-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.